The trend is there based on interim data. I would assume someone would want to see more mature data first. I know I would. The question to me is what kind of term they would get. In the hands of a bigger, experienced company, they can have more comprehensive development plan, not just in this highly refractory patient population.
Market Data 
Markets 
AI
